Cancer Type: Leukaemia
Search News
Categories
Archives
Dr Diu Nguyen
6th April 2022
The overarching goal of our laboratory is to understand the biology of normal haematopoietic and leukaemic stem cells in order to selectively kill cancer stem cells for better leukaemia treatment.
Read moreDr Ana Levi
5th May 2021
My focus is on investigating the epigenetic regulation of the PI3K pathway and identifying an effective combination therapy that will disable compensatory bypass routes, overcoming drug resistance.
Read moreDr Christopher Mapperley
22nd April 2021
My research is focused on investigating how the epitranscriptome regulates normal and malignant haematopoiesis.
Read moreDr Miguel Ganuza
6th February 2020
Our goal is to identify mechanisms that support haematopoietic stem cell function and understand how the leukaemic stem cells “play” with these mechanisms to thrive.
Read moreDr Paolo Gallipoli
17th September 2019
My research interests focus on mechanisms of disease initiation and maintenance and the identification and validation of novel therapeutic targets in myeloid leukaemias.
Read moreDr Marta Crespi-Sallan
20th December 2018
My research is focused on describing the mechanisms underlying Lamin B1 nuclear disassembly in B-cell normal development and how a dis-regulated Lamin B1 removal pathway could lead to several haematological malignancies within the germinal centre in secondary lymph organs.
Read more